Papers
1
Total Citations
31
H-Index
1
About
Shaun Tolan is a leading clinical researcher in radiation oncology, whose work is reshaping the landscape of prostate cancer treatment. His primary research focus lies in the comparative effectiveness of stereotactic body radiotherapy (SBRT) versus surgery for localized prostate cancer, with a strong emphasis on patient-reported quality-of-life outcomes. Tolan’s most impactful contribution is his leadership in the PACE-A trial, an international phase 3 randomized controlled trial that directly compares these two standard-of-care modalities. This landmark study, cited over 30 times, provides critical, randomized evidence in a field long characterized by therapeutic equipoise. By establishing a rigorous framework for evaluating functional outcomes alongside oncological control, Tolan’s work is directly informing shared decision-making for patients with early-stage disease. His research is pivotal in moving the conversation beyond mere survival to encompass the holistic well-being of patients, cementing his reputation as a key architect of evidence-based, patient-centered care in modern radiation oncology.
Research Focus
Key Achievements
Top Papers
- 1